4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-009344
CHIEF ACCOUNTING OFFICER acquired 703 shares (grant or award)
- CHIEF ACCOUNTING OFFICER gave up 228 shares (to pay taxes)
- CHIEF ACCOUNTING OFFICER acquired 775 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2022-07-15 | Grant or award | +703 | $9.56 | $6,721 | 6,744 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2022-09-02 | Option exercise | +775 | 7,519 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2022-09-02 | Shares withheld for taxes | −228 | $11.44 | $2,608 | 7,291 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2022-09-01 | Grant or award · Share Option | +31,460 | 31,460 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2022-09-01 | Grant or award · Restricted Share Unit | +15,730 | 15,730 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2022-09-02 | Option exercise · Restricted Share Unit | −775 | 2,323 | D | ||
Loading xslF345X03/form4-09062022_010922.xml…